Dennis Kim, MD, PhD
Professor of Pediatrics, Emory University School of Medicine
Director, Cardiac Catheterization Laboratories. Pediatric Cardiologist, Children’s Healthcare of Atlanta
Dennis Kim, MD, PhD is a board-certified interventional cardiologist for both pediatric and adult congenital heart patients and serves as the Director of the Pediatric Cardiac Catheterization Labs at the Children’s Healthcare of Atlanta Heart Center. In addition to providing patient care, Dr. Kim holds an academic appointment, serving as a Professor of Pediatrics at the Emory University School of Medicine to train the next generation of pediatric cardiologists.
Dr. Kim received his medical education at the University of Texas Medical Branch at Galveston and completed his residency in pediatrics at the University of Michigan in Ann Arbor, MI. Dr. Kim completed pediatric cardiology and pediatric interventional cardiology fellowships at the University of Michigan Congenital Heart Center, receiving focused training in advanced cardiac therapies and catheterization techniques. In his role as Director of the Pediatric Cardiac Catheterization Labs, Dr. Kim ensures that the Children’s Heart Center provides the full spectrum of diagnostic and interventional capabilities to deliver the best possible heart care to patients. He is skilled in interventional procedures and minimally invasive treatments for congenital heart disease, such as transcatheter valve replacement and septal defect repair, and is involved in a variety of clinical trials for new transcatheter device therapies.
Dr. Kim's research interests revolve around novel transcatheter treatments for congenital heart disease, both in children and in adults. He has been the site primary investigator for many clinical device trials at CHOA and Emory University. These have involved cardiac devices in their initial clinical trial phases as well as comparative studies such as the COMPASS trial comparing surgical aortopulmonary shunts to ductal stenting. Transcatheter treatments of adults with congenital heart disease are a fertile area for investigation as many of these patients do not want disruption to life surgery if catheter-based options are available. Also, many of these patients are not surgical candidates due to additional medical comorbidities. Additionally, novel devices are being developed in conjunction with the NIH/NHLBI for transcatheter bidirectional Glenn and Fontan applications.
Research Areas of Interest
- Transcatheter cardiac devices
- Multi-institutional device trials
- Novel transcatheter treatments for adult congenital heart disease
- The University of Texas Medical Branch, Galveston, TX
- Pediatric Internship & Residency, University of Michigan Hospitals, Ann Arbor, MI
- Pediatric Cardiology, Michigan Congenital Heart Center, University of Michigan, Ann Arbor, MI
- Subspecialty Training in Pediatric Interventional Catheterization, Michigan Congenital Heart Center, University of Michigan, Ann Arbor, MI